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27 The contribution of proteoglycans (PGs) to the viscoelasticity of soft tissues such as 
28 ligaments is highly debated in current literature. To date, there is limited information on the 
29 mechanical role of PGs to the anterior cruciate ligament (ACL) in the knee joint which is 
30 both highly susceptible to injuries and contains higher PGs content compared to the collateral 
31 ligaments. 
32 This is the first study to collectively investigate the contribution of PGs to key viscoelastic 
33 characteristics (strain-rate dependency, recovery, hysteresis, creep and stress-relaxation) in 
34 the knee joint femur-ACL-tibia complex. 
35 Femur-ACL-tibia complexes (n=6 pairs) were harvested from disease-free canine knee joints 
36 and categorised into control and PGs-reduced groups. Specimens were preconditioned and 
37 cyclically loaded to 9.9 N at 0.1, 1 and 10%/min strain-rates followed by creep and stress-
38 relaxation tests. Low tensile loads were applied to focus on the toe-region of the stress-strain 
39 curves where the non-collagenous extracellular matrix components are believed to take 
40 effect. Subsequently biochemical assays were performed on the ACLs to determine PGs and 
41 water content. 
42 Reduced PGs content in the ACLs significantly increased stress-relaxation (p<0.05) while it 
43 significantly decreased recovery (p< 0.01) and creep (p< 0.05). However, PGs had no effect 
44 on the stress-strain behaviour and hysteresis of the ACLs. The current study shows that 
45 altering PGs content can lead to changes in ACL viscoelasticity, which may predispose to 
46 injury and eventually leading to knee joint osteoarthritis.
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52 Knee ligaments are essential to knee joint stability being defined by their material 
53 composition which contributes to their complex mechanical characteristics [1–4]. Knee 
54 ligaments are strong fibrous tissues consisting of cellular material and extracellular matrix 
55 (ECM) proteins such as collagen type I [1]. The viscoelastic properties of ligaments are 
56 thought to come from viscous and elastic properties of the collagen fibres [5], interaction of 
57 collagen fibres with other non-collagenous components in the ECM such as elastin and 
58 proteoglycans (PGs) [1,6–9], and fluid movement [10]. In particular, the interaction between 
59 sulphated glycosaminoglycans (sGAGs), which are components of proteoglycans (PG), such 
60 as dermatan and chondroitinase sulphate with collagen fibrils in knee medial collateral 
61 ligaments has been reported to increase permeability and decrease peak stress [7]. 
62 PGs comprise 0.2 - 5% of ligament dry weight and are either non-aggregating (small leucine-
63 rich proteoglycan (SLRPs) such as decorin and biglycan) or large aggregating PGs (versican 
64 and aggrecan) [11–14]. They are made up of a protein core and sulphated GAGs [15]. 
65 Approximately 90% of the total PGs in the fresh collateral ligament is the SLRP, decorin and 
66 the remaining PGs include biglycan, aggrecan and versican [16]. Dermatan and chondroitin 
67 sulphate are the sGAG chains of the SLRPs decorin and biglycan [15,17]. The interactions 
68 between these two PGs with collagen fibrils differ, such that decorin binds to collagen fibrils 
69 through its core protein whereas biglycan and the large PGs, aggrecan and versican, bind to 
70 collagen fibrils through their sGAG chains [14,18,19]. Interactions between the sGAG chains 
71 form interfibrillar PG bridges and these bridges are believed to contribute to mechanical 
72 characteristics of collagenous tissues [19,20]. Several studies have shown that decorin 
73 contributes to the organisation and mechanical properties of soft tissues such as the skin [21–
74 23] and tendons [24–26]. The role of the sGAG chains to tissue mechanics has been 
75 particularly important at low stress and strain levels [22,27]. In a study using rat dorsal skin, 














76 it was found that PGs control the skin’s response at low strain level where the collagen fibres 
77 were still crimped (toe region of stress-strain behaviour) [22]. Similarly, the sGAG content in 
78 porcine aortic heart valve leaflets may provide a damping mechanism reducing aortic valve 
79 leaflet flutter when the leaflet is not under high tensile stress, reportedly due to strong 
80 associations with fibre-fibre and fibre-matrix interaction at low stress levels [27]. In addition 
81 to the cross-linking function of sGAG, the chains of sGAG may affect hydration of soft 
82 tissues due to its highly negative charges [28–30]. The water molecules bound with sGAG 
83 can act as a lubricant between collagen fibrils [20] and facilitate sliding of the fibrils during 
84 tensile stretches [5], hence affecting viscoelastic properties of ligaments [10,30,31]. 
85 Investigation on the mechanical role of sGAGs in the knee ligaments is limited and the 
86 previous literature focused on the medial collateral ligaments [7,32,33]. These studies 
87 reported that the interactions between sGAGs and collagen fibrils had no impact on the 
88 viscoelastic, tensile and resistance properties [32,33]. However, permeability of the medial 
89 collateral ligament was found to increase with the reduction of sGAG [7] which could be an 
90 indication that sGAGs contribute to the mechanical properties of knee ligaments through 
91 maintaining tissue hydration. A limitation of these studies was that extracted sections of the 
92 ligaments, which might have altered the microstructural organisation of the specimens, were 
93 examined, instead of testing intact ligaments with their bone attachments ex vivo [7].
94 In the knee joint, the anterior cruciate ligament (ACL) is the ligament most susceptible to 
95 injuries [34] and contains a higher PGs content compared to other knee ligaments [14,35] 
96 which likely contribute to the structural integrity of the tissues. Therefore, it is our hypothesis 
97 that a reduction in PGs content would affect the contribution of ECM composition to the 
98 structural integrity in the ACL, resulting in altered ligament mechanics which may ultimately 
99 lead to ACL injury and knee joint osteoarthritis [36]. Thus, the aim of this study was to carry 
100 out an extensive investigation on the role of PGs to the viscoelastic properties (strain-rate 













101 dependency, recovery, hysteresis, creep and stress-relaxation) of intact femur-ACL-tibia in an 
102 ex vivo test environment. 
103  
104 2 Material and Methods
105 2.1 Specimen storage, preparation and purpose
106 Paired disease-free knee joint cadavers (n=6) from skeletally mature Staffordshire bull terrier 
107 canines were obtained with full ethical permission from the Veterinary Research Ethics 
108 Committee ((VREC65), University of Liverpool). Inclusion criteria were knee joints from 
109 skeletally mature animals with a bodyweight >20 kg. The entire knee joints were frozen at -
110 20°C until required and defrosted at room temperature for extracting the ACL as a femur-
111 ACL-tibia complex [37–39]. ACL complexes from the right knees were not treated to reduce 
112 the PGs content (control group), whilst the ACL complexes from the left knee joints were 
113 treated to reduce the PGs content (PGs-reduced group).
114
115 2.2 Specimen length and cross-sectional area
116 The ACL lengths were determined between the insertion and origin of the ligaments at the 
117 cranial, caudal, lateral and medial planes using Vernier callipers (D00352, Duratool, Taiwan) 
118 accurate to ±10 µm [40,41]. The mean values of these four length measurements were used in 
119 the calculations of engineering strains [38,39]. The method by Goodship and Birch was used 
120 to measure the cross sectional area (CSA) of the ACLs [42]. In brief, alginate dental 
121 impression paste (UnoDent, UnoDent Ltd., UK) was used to make a mould around the ACL 
122 and this mould was used to create replicas of the ligament. The replicas were cut in half and 














123 the surface of the replicas showing middle CSA was determined using ImageJ (a public 
124 domain Java image processing program) [38,39]. The CSA values were then used in the 
125 calculations of engineering stress. 
126
127 2.3 Chondroitinase treatment protocol
128 The ACLs from both groups were immersed for one hour at room temperature (20°C) in 20 
129 ml buffer solution (15 ml of 20 mM Tris pH 7.5, 150 mM NaCl, 5 mM CaCl2) with protease 
130 inhibitors (1 tablet of mini-cOmplete per 10 ml of buffer, SIGMA-ALDRICH/Roche, USA) 
131 [33]. To reduce the PGs content, chondroitinase ABC (ChABC) 0.25 IU/mL (SIGMA-
132 ALDRICH, USA) enzyme was dissolved in 0.01% bovine serum albumin (BSA) and samples 
133 were incubated in this solution for three hours prior to the mechanical tests as previously 
134 described [33]. This incubation time and enzyme concentration were based on our 
135 preliminary work which showed that approximately 80% of PGs in sectioned ACLs were 
136 digested within 3 hours of incubation (Supplementary Materials (Table S1 and Figure S1)). 
137 Both control and PGs-reduced groups were preserved during the mechanical tests in a 
138 custom-built tank filled with 600ml of the buffer solution and protease inhibitors at room 
139 temperature (20°C) (1 tablet of cOmplete Protease Inhibitor Cocktail per 50ml of buffer, 
140 SIGMA-ALDRICH/Roche, USA). 
141
142 2.4 Mechanical testing protocol
143 Each femur-ACL-tibia complex examined was attached to an Instron 3366 (Instron, 
144 Norwood, MA) material testing machine fitted with a 10 N load cell (Instron 2530-428 with 
145 ±0.025 N accuracy) using a custom-built stainless steel ducktail clamp and rig [37,39]. A pre-














146 load of 0.1 N was applied, followed by five load-unload preconditioning cycles to a 
147 maximum load of 9.9 N at strain-rate of 10 %/min [43–46]. Subsequently, mechanical tests 
148 examining strain-rate, creep and stress-relaxation behaviours were performed. The strain-
149 rate tests consisted of (i) two loading cycles at 0.1 %/min strain-rate; (ii) three loading cycles 
150 at 1 %/min strain-rate; and (iii) two loading cycles at 10 %/min strain-rate. These loading 
151 cycles were successively applied, followed by two cycles for creep testing and two for stress-
152 relaxation testing.
153 The creep behaviour of the ACLs was determined by subjecting the ligament to tensile loads 
154 of 4.9 N and 9.9 N that remained constant for 15 minutes each. For the stress-relaxation tests, 
155 the ACLs were extended by applying a 9.9 N tensile load and monitoring the gradual 
156 decrease in tissue stress over a 15-minute period whilst the extension of the ligament was 
157 held constant. Loading and unloading during creep and stress-relaxation tests were performed 
158 at 1 %/min strain-rate. A recovery period of six minutes was applied between each loading-
159 unloading cycle to minimise the effect of the strain history of previous cycles on subsequent 
160 behaviour [37,39]. 
161 Following completion of the mechanical tests, the middle section of each ACL was extracted 
162 in preparation for the biochemical assays to determine water and sGAG contents in both 
163 control and PGs-reduced groups [47].
164
165 2.5 Biochemical assays
166 2.5.1 sGAG content quantification
167 ACLs in the control and PGs-reduced groups were digested for 48 hours with 10 unit/ml 
168 papain in 100 mM sodium acetate, 2.4 mM ethylenediaminetetraacetic acid (EDTA) and 5 














169 mM cysteine hydrochloric acid (HCL) at 60°C [47]. Dimethylmethylene blue (DMMB) dye 
170 binding assay (1, 9-dimethylmethylene blue) was used to determine the sGAG content of the 
171 ACLs [14,47]. Subsequently, 250 µl of DMMB dye was added to 40 µl duplicates of papain-
172 digested ACLs, and this was immediately analysed at 570 nm wavelength. Shark chondroitin 
173 sulphate over a concentration range of 0-75 µg/ml was used as a standard and sGAG content 
174 was calculated by comparison with the standard line [14,33]. 
175
176 2.5.2 Water content quantification
177 The water content of the ACL in both groups was expressed in terms of the mass of water per 
178 unit mass of the wet ligament (Equation 1) as described previously [33,48]. Initially, the 
179 ACLs were left to thaw at room temperature (20°C) and wet mass was measured. 
180 Subsequently, these samples were freeze dried overnight and then the dry masses of the 
181 ACLs were measured. 
𝑊𝑎𝑡𝑒𝑟 𝐶𝑜𝑛𝑡𝑒𝑛𝑡 (%) =  
𝑊𝑒𝑡 𝑚𝑎𝑠𝑠 ‒ 𝐷𝑟𝑦 𝑚𝑎𝑠𝑠
𝑊𝑒𝑡 𝑚𝑎𝑠𝑠 × 100 Equation 1
182
183 2.6 Viscoelastic data analysis
184 Analyses of the load-deformation data were performed using MATLAB (MATLAB R2020a). 
185 Equations 2 and 3 were used to calculate engineering stress and strain values [49,50]. 
186 Subsequently, tangent modulus values describing stiffness of the ACLs were determined 
187 (Equation 4). Numerical integration (using the trapezoidal rule) of the load-unload stress-
188 strain curves was used to estimate the stored energy in the ligaments (Equation 5). The 
189 hysteresis (dissipated energy) was then calculated from the difference between the stored 













190 energy during loading and unloading cycles [51] (Equation 6). In addition, ACL extensions 
191 recorded before and after the six-minute rest were studied to investigate tissue recovery. 
192 Creep behaviour was determined from the strain-time curves while the stress-relaxation 
193 behaviour was determined from the stress-time curves. To compare relaxation behaviour 
194 across ligaments, stress values were normalised by the peak stress at the test start time (t=0) 
195 [44]. 
196




where  is stress in MPa,  is applied load in N and  is cross-sectional area at the 𝜎 𝐹 𝐶𝑆𝐴
middle of the ACL in mm2.




where  is strain,  is change in length in mm ( ),  is initial length and  is 𝜀 ∆𝐿 ∆𝐿 = 𝐿1 ‒ 𝐿0 𝐿0 𝐿1
deformed length of the ACL in mm.




where  is tangent modulus in MPa.𝐸𝑡𝑎𝑛



















2 × (𝜎𝑘 ‒ 1 + 𝜎𝑘) × ∆𝜀𝑘 Equation 5
where  is the stored energy in MPa,  is the resolution of the trapezoidal partition, and 𝑈 𝑁 ∆
is the length of the  interval ( ). 𝜀𝑘 𝑘𝑡ℎ ∆𝜀𝑘 = 𝜀𝑘 ‒ 𝜀𝑘 ‒ 1
𝐻𝑦𝑠𝑡𝑒𝑟𝑒𝑠𝑖𝑠 =  𝑈𝐿𝑜𝑎𝑑𝑖𝑛𝑔 ‒ 𝑈𝑈𝑛𝑙𝑜𝑎𝑑𝑖𝑛𝑔 Equation 6
where  and  represent the stored energy during the loading and unloading 𝑈𝐿𝑜𝑎𝑑𝑖𝑛𝑔 𝑈𝐿𝑜𝑎𝑑𝑖𝑛𝑔
of the ligaments, respectively, in MPa.
197
198 2.7 Statistical Analysis
199 Statistical analysis was performed on viscoelastic characteristics and biochemical data using 
200 GraphPad Prism (Version 9.0.0, GraphPad Prism Software, USA). Normal (Gaussian) 
201 distribution for each dataset was assessed with D’Agostino-Pearson normality test. 
202 Subsequently, all datasets were assessed for outliers using ROUT method (nonlinear 
203 regression method) with the maximum false discovery rate Q=1%. The biochemical assays 
204 results were analysed using a paired t-test (differences between paired values were assumed 
205 consistent). In the stress-strain, tangent modulus, hysteresis, recovery, and creep datasets 
206 some values were missing after removing the outliers; therefore, these data were analysed by 
207 fitting a mixed model, rather than by repeated measures analysis of variance (ANOVA) 
208 (which cannot handle missing values). However, for the stress-relaxation dataset repeated 
209 measure one-way ANOVA was performed. The ANOVA tests were followed by multiple 













210 comparisons using uncorrected Fisher’s Least Significant Difference. For all statistical 
211 analyses the significant level was set at 95% confidence interval (p <0.05). 
212
213 3 Results
214 3.1 Specimen characteristics
215 The ACL specimens (n=6 paired knee joints) were of mixed gender (female = 1 and male = 
216 5) and the bodyweight of the cadavers was in the range of 21.5 to 29.4 kg (mean ± standard 
217 deviation: 25.76 ± 3.12 kg).
218
219 3.2 Specimen length and cross-sectional area
220 The ACLs’ mean lengths and CSA ranged from 14.58 to 19.25 mm (mean ± standard 
221 deviation: 16.42 ± 1.33 mm) and from 16.07 to 31.57 mm2 (mean ± standard deviation: 23.79 
222 ± 5.08 mm2), respectively. The length and CSA of each ACL can be found in the 
223 Supplementary Materials (Table S2 and Table S3).
224
225 3.3 Biochemical assays
226 3.3.1 sGAG content
227 The depletion process reduced sGAGs by approximately 19% in the PGs-reduced group 
228 (Table 1). The sGAG content of the ACLs in the PGs-reduced group was ranged from 1.7 to 
229 4.7% (mean ± standard deviation: 3.1 ± 1.1%) as a percentage of dry weight, whereas the 














230 range was 2.2 to 6.6% (mean ± standard deviation: 3.8 ± 1.6%) in the control group. There 
231 were not any statistically significant differences between the control and PGs-reduced groups 
232 (p> 0.05).
233
234 3.3.2 Water content
235 The depletion process reduced water content by approximately 4% in the PGs-reduced group 
236 (Table 2). The water content of the ACLs in the PGs-reduced group was ranged from 65.7 to 
237 73.3% (mean ± standard deviation: 69.4 ± 3.0%), whereas the range was 64.7 to 77.4% 
238 (mean ± standard deviation: 72.3 ± 4.2%) in the control group. There were not any 
239 statistically significant differences between the control and PGs-reduced groups (p> 0.05).
240
241 3.4 Mechanical properties
242 3.4.1 Stress-strain
243 The experimental setup was designed to focus on the toe-region of the stress-strain curves 
244 where the extracellular matrix, including the PGs, is expected to affect the ACL mechanics  
245 [7,22,27,33].  The stress-strain curves of the ACLs in the control and PGs-reduced groups 
246 followed a similar pattern during loading (Fig. 1a) and unloading (Fig. 1b) cycles. 
247 The ACLs in the PGs-reduced group had higher stress than in the control group (Fig. 2a, b 
248 and c). During loading at 0.1 %/min strain-rate, the median stresses at 1, 2, and 3% strains 
249 were 0.04, 0.11 and 0.22 MPa in the control and 0.06, 0.16 and 0.28 MPa in the PGs-reduced 
250 groups. Similar patterns were found during loading at 1 and 10%/min strain-rates. However, 
251 these variations in stress were not statistically significant (p> 0.05). 














252 It is important to note that the stress-strain values for individual specimens, indicated by the 
253 grey dots, were scattered and not all specimens reached 5% strain (Supplementary Materials 
254 (Fig. S2)). 
255 Stress-strain behaviour were minimally strain-rate dependent and only in the control group. 
256 The statistically significant difference was found only at 2% strain during loading at 0.1 and 
257 10%/min were statistically different (p=0.04).
258
259 3.4.2 Tangent modulus
260 The tangent modulus of the ACLs increased with increasing stress in both groups (Fig. 2d, e 
261 and f). However, the ACLs in the control group had lower median tangent modulus compared 
262 to ligaments in the PGs-reduced group. At 0.1%/min strain-rate, the median tangent modulus 
263 at 0.1, 0.2 and 0.3 MPa stresses were 8.3, 11.14 and 13.63 MPa, respectively, in the control 
264 and 9.97, 13.12 and 14.82 MPa in the PGs-reduced groups. Similar patterns were found 
265 during loading at 1 and 10%/min strain-rates. These variations in tangent modulus were 
266 statistically significant only at 0.1 MPa stress during loading at 0.1 and 1%/min strain-rates 
267 (p= 0.01 and p= 0.04, respectively) (Fig. 2d and e).
268
269 3.4.3 Hysteresis 
270 As shown in Fig. 3a, initially hysteresis in the ACLs decreased after the preconditioning 
271 cycles, then experienced a plateau during mechanical tests at 0.1 and 1%/min strain-rates, and 
272 finally increased with 10%/min strain-rate to a level that was similar to that observed at the 
273 preconditioning cycles. The decrease in the mean dissipated energy was largest from the last 














274 preconditioning cycle to the second cycle of mechanical tests at 0.1%/min strain-rate, this 
275 decrease was approximately 1.5% and 1.2% in the control and PGs-reduced groups, 
276 respectively. To test repeatability, loading at 1%/min strain-rate consisted of three loading 
277 cycles and the mean dissipated energy across all three cycles were only minimally different 
278 by approximately 0.04% and 0.03% in the control and PGs-reduced groups, respectively.
279 Hysteresis might appear to be lower in the PGs-reduced compared to the control group (Fig. 
280 3b); however, results were not statistically different (p>0.05). Hysteresis was strain-rate 
281 dependent in both groups with statistical differences found between 0.1 and 10%/min strain-
282 rates (p<0.0001 in control and PGs-reduced groups), and 1 and 10%/min strain-rates 
283 (p<0.0001 in control and PGs-reduced groups).
284
285 3.4.4 Recovery 
286 Recovery, determined by the difference in specimen length before and after the rest period 
287 between each two consecutive load cycles, reached a near plateau after the last 
288 preconditioning cycle. These values ranged between 0.087 and 0.079 mm in the control group 
289 and between 0.049 and 0.039 mm in the PGs-reduced group (Fig. 4a). 
290 The ACLs in the control group recovered more than those with reduced PGs content during 
291 loading at strain-rates of 1%/min (p= 0.0048) and 10%/min (p= 0.0019) (Fig 4b). For 
292 example, during mechanical tests at 1%/min, the median recovery of ACLs in the control 
293 group was 2.6% higher than those with reduced PG. Furthermore, recovery was strain-rate 
294 dependent in the control group only and statistical differences were found between 0.1 and 
295 1%/min strain-rates (p= 0.0031), and 0.1 and 10%/min strain-rates (p= 0.0007).
296















298 The strain-time curves, indicating creep rates, showed an increase in strain with time in both 
299 control and PGs-reduced groups (Fig. 5a and b).  As shown in Fig. 5c and d, the strains were 
300 higher in the control compared to the PGs-reduced groups during creep load of 4.9 N (p= 
301 0.017, p= 0.0013, p= 0.013 and p= 0.0045 at 3, 6, 9 and 12 minutes respectively) and 9.9 N 
302 (p= 0.013, p= 0.001 and p= 0.0001 at 6, 9 and 12 minutes respectively).
303 Furthermore, increasing creep load from 4.9 N to 9.9 N resulted in strain increase at 9 and 12 
304 minutes in the control group (p= 0.0079 and p= 0.0008) and at 12 minutes in the PGs-
305 reduced group (p= 0.049). The strain-time behaviour observed in creep tests on individual 
306 specimens can be found in the Supplementary Materials (Fig. S3).
307
308 3.4.6 Stress-relaxation
309 The stress-time curves, demonstrating stress-relaxation rates, showed reduction in stresses 
310 with time in both control and PGs-reduced groups (Fig. 6a). The stress-relaxation was larger 
311 in the PGs-reduced compared to the control groups during the initial nine minutes (p 
312 <0.0001, p <0.0001, and p= 0.013 at 3, 6, and 9 minutes respectively) (Fig. 6b). For 
313 example, after three minutes of stress-relaxation, the median stress had reduced by 52.7% in 
314 the control group and 58.8% in the PGs-reduced group. Stress-relaxation behaviour of 
315 individual specimens can be found in the Supplementary Materials (Fig. S4).
316














318 It was the hypothesis of this study that altering PGs content in the ACLs, which changes the 
319 composition of the ligaments, might affect the structural integrities of the ACL. This 
320 compositional change is clinically important because it can cause alterations in ligament 
321 mechanics, possibly predisposing to ACL injury, and ultimately knee joint osteoarthritis [36].  
322 Therefore, the aim of this study was to carry out an extensive investigation on the 
323 contribution of PGs to the viscoelastic behaviour of intact femur-ACL-tibia, in particular the 
324 role of PGs to the strain-rate dependency, hysteresis, recovery, creep, and stress-relaxation of 
325 the ACLs. Here, we found statistically significant alterations in the key viscoelastic 
326 characteristics of the ACLs as a result of PGs reduction, in particular changes were found in 
327 tissue recovery, stress-relaxation and creep. However, stress-strain behaviour and hysteresis 
328 were unaffected by the reduction in the PGs content. 
329 The design of experiments and mechanical tests were performed based on our previous work 
330 [37,39] and preliminary investigations [52]. The mechanical tests focused on investigating 
331 the toe-region of the stress-strain curves, where the collagen fibres are crimped and sGAG 
332 chains are believed to have mechanical contribution to tissues [22,27,33], hence in this study 
333 we examined loads up to 10 N at three slow strain-rates [39,49].
334 The ACL properties such as length and the cross-sectional area in the mid-ligament regions 
335 were determined and used in the calculations of engineering stress and strain values, and 
336 these properties were in a range similar to those previously reported for canine ACLs [53]. 
337 When determining the incubation process of the ACLs in chondroitinase ABC (ChABC), our 
338 preliminary time-course study showed that after three hours of incubation in 0.25 IU/ml 
339 ChABC, sGAG content was significantly reduced by approximately 82.3% (Supplementary 
340 Materials (Fig. S1)) similar to previous studies [7,32,33]. However, unlike the current study, 














341 the preliminary investigation was carried out on ACLs that were transversely cut to extract 
342 their middle sections as opposed to intact femur-ACL-tibia complex. The transverse cut of 
343 the ACLs in the preliminary investigation might have disrupted the synovial sheath, allowing 
344 better infiltration of the enzyme, hence higher reduction of the sGAG content. The ACL is 
345 surrounded by vascularised synovial tissue (synovial sheath) which protects the ligament’s 
346 core tissue from exposure to synovial fluid and hence degradation [54–56]. The ACLs can be 
347 described as fibre-reinforced matrix and approximately 70% of the ACLs are water. The 
348 water content in the ACLs is associated with sGAG chains and these chains bind with water 
349 molecules because of their highly negative charges [28–30]. In this study, reducing PGs 
350 content led to the reduction in water content by approximately 4% which was not statistically 
351 significant. However, this change in water content may indicate that when the sGAG chains 
352 are reduced, the matrix had lost water-binding sites, hence the ACL reduced the capacity to 
353 retained water.
354 The effect of change in the sGAG and hence water content on the viscoelastic characteristics 
355 of ACLs were studied by investigating the strain-rate dependency, hysteresis, recovery, 
356 creep, and stress-relaxation. The stress-strain behaviour of the ACLs was unaffected by the 
357 reduction of the PGs content (Fig. 1a, b and c). This outcome agrees with the conclusions in 
358 the human medial collateral ligament study where the removal of dermatan sulphate showed 
359 no effect on quasi-static tensile property [32]. The stress-strain behaviour of the ACLs in the 
360 control group was minimally strain-rate dependent, however, this rate dependency diminished 
361 in the PGs-reduced group. This is similar to a study on mice tendon where tendon fascicles 
362 without decorin had reduced strain-rate sensitivity [57]. Furthermore, there were not any 
363 statistically significant differences in hysteresis between the two groups which is similar to 
364 the previous literature [32]. Hysteresis of the ACLs in the control group was strain-rate 
365 dependent and this characteristic did not change after PGs reduction. However, strain-rate 














366 dependency in recovery diminished after the reduction of PGs content. In addition, reducing 
367 PGs content led to significantly less ACL length recovery (Fig 4b). The decrease in recovery 
368 may be linked with the decrease in water content as a result of changes in the sGAG chains. It 
369 might be that without water molecules to act as lubricant and facilitate sliding of collagen 
370 fibrils, the ACLs may take longer to recover [5,20,58]. 
371 The decrease in creep (Fig. 5) can be a result of the decreased hydration [30]. However, when 
372 more water molecules are present the resistance to creep is decreased because water provides 
373 a greater freedom for fibrillar movement [30]. Similarly, Murienne et al. associated the 
374 slower creep rate with increased interfibrillar friction with sGAG removal [29]. Reducing 
375 sGAG chains caused an increase in stress-relaxation (Fig. 6) and at the low strain level, 
376 stress-relaxation is likely occurred through sliding between collagen fibres [59]. Similarly, 
377 larger and faster stress-relaxation in mouse tail tendon decorin knockout [60], and also in 
378 mice tendon fascicles [58]. However, Lujan et al. showed a small and negligible increase in 
379 stress-relaxation after reducing sGAG in human medial collateral ligament [33]. The 
380 increased stress-relaxation after reducing sGAG can cause fatigue damage in the ACLs which 
381 highlights the important role of sGAG in tissue mechanics possibly by maintaining ligament 
382 hydration. 
383 There were several limitations to our study and one of which was the small reduction in 
384 sGAGs which was not statistically significant between both groups of femur-ACL-tibia 
385 complexes. Although sGAG content was reduced by only 19% in the PGs-reduced group, this 
386 reduction altered recovery, stress-relaxation, and creep behaviour of the ACLs.  In addition, 
387 preparing ACLs for mechanical tests as a whole unit (femur-ACL-tibia complex) might have 
388 resulted in overlooking the complexity of the anatomical structure of the ligament. Finally, 
389 the approximation methods adopted to measure the cross-sectional area and length of the 














390 ACLs might be considered as another limitation. However, these methods were selected 
391 because of their non-destructive and anatomically comparable approach. Further investigation 
392 with a larger number of specimens might improve the reliability of the statistical analysis and 
393 provide a broader view on the effect of cadaveric demography (i.e. age, gender, bodyweight) 
394 on the mechanical properties of knee ligaments [61–63]. 
395 In conclusion, to the authors’ knowledge this study is the first to investigate contribution of 
396 PGs to key viscoelastic characteristics of the femur-ACL-tibia complex in the knee joint. We 
397 have shown that reducing sGAG chains in the ligaments increased stress-relaxation while it 
398 decreased recovery and creep. However, PGs did not contribute to the stress-strain behaviour 
399 and hysteresis of the ACLs. Given the small reduction in the sGAGs, water content in the 
400 ACLs was only minimally reduced. Some of the results were not statistically significant and 
401 that is possibly due to the small specimen size and limited reduction in sGAG content. Our 
402 results suggest that the role of sGAG is important in maintaining water content in the tissue, 
403 which in effect contributes to the viscoelasticity of the ACLs and ultimately knee joint 
404 stability.  
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Figure 1: A representative example of stress-strain curves of an anterior cruciate ligament (ACL) at different 
strain-rates during (a) loading and (b) unloading tensile tests. The lines in red shades show results from an 
ACL in the control group whereas the lines in black shades show results from the contralateral ACL in the 
proteoglycans (PGs) reduced group.






































Figure 2: Tensile characteristic such as the stress-strain curves and tangent modulus values were determined for the anterior cruciate ligaments (ACLs) in the 
control (red line) and proteoglycans (PGs) reduced (black line) groups at varying strain-rates. The box plots show; individual specimen values (grey dots), 
stress at 1, 2, 3 and 4% strain during loading at (a) 0.1 %/min, (b) 1 %/min and (c) 10 %/min strain-rates, and tangent modulus at 0.1, 0.2, 0.3 and 0.4 MPa 
stress during loading at (d) 0.1 %/min, (e) 1 %/min and (f) 10 %/min strain-rates. The outliers are indicated with a red plus sign and statistically significant 
differences are indicated by a blue line with an overhead asterisk. 













Figure 3: Dissipated energy (hysteresis) of the anterior cruciate ligaments (ACLs) during cyclic loading at 
varying strain-rates for the control (red lines) and proteoglycans (PGs) reduced (black lines) groups.  (a) The 
change in the mean dissipated energy across all the loading cycles for both groups. The first five cycles 
represent dissipated energy during the precondition while cycles six to twelve are showing dissipated energy 
during tensile tests at three different strain-rates (0.1, 1 and 10 %/min with each test repeated at least twice). 
The mean dissipated energy appears to be higher in the control compared to the PGs-reduced groups. (b) 













The box plot shows the different dissipated energy values across specimens (grey dots) and the dissipated 
energy increases with increasing strain-rates for both groups. The outliers are indicated with a red plus sign.















Figure 4: Recovery of the anterior cruciate ligaments (ACLs) during cyclic loading at varying strain-rates 
for the control (red lines) and proteoglycans (PGs) reduced (black lines) groups. (a) The mean recovered 
length of the ACLs at different cycles shows that the ACLs in the control group recovers more than the PGs-
reduced group. (b) The box plot shows different recovery values across specimens (grey dots) and the 
recovered lengths increase with increasing strain-rates for both specimen groups. The outliers are indicated 













with a red plus sign and statistically significant differences are indicated by a blue line with an overhead 
asterisk.
































Figure 5: Creep behaviour of the anterior cruciate ligaments (ACLs) in the control (red lines) and proteoglycans (PGs) reduced (black lines) groups was 
determined by applying constant loads of 4.9 N and 9.9 N for 15 minutes each. An example of creep rate in an ACLs during loading at (a) 4.9 N and (b) 9.9 N. 
Strains of the ACLs in the control was higher than those in the PGs-reduced groups. The box plots show different creep rates across specimens (grey dots) 
during loading at (c) 4.9 N and (d) 9.9 N. The outliers are indicated with a red plus sign and statistically significant differences are indicated by a blue line with 
an overhead asterisk. 













Figure 6: Normalised stress-relaxation behaviour of the anterior cruciate ligaments (ACLs) in the control 
(red lines) and proteoglycans (PGs) reduced (black lines) groups. This viscoelastic characteristic was 
determined by holding deformation caused by a load of 9.9 N for 15 minutes. (a) An example of stress-time 
curves of a representative ACL showing a decrease in stress with time. (b) The box plot shows different 
stress-relaxation across specimens (grey dots) and the stresses of the ACLs in the control group were higher 
than those in the PGs-reduced group. The statistically significant different values are indicated by a blue line 
with an overhead asterisk.













Table 1: The sulphated glycosaminoglycan (sGAG) contents of the anterior cruciate 
ligaments (ACLs) in the control and proteoglycans (PGs) reduced groups. 
Microgram of sGAG per mg dry weight of the ACL (%)ACL Specimens








Standard Deviation 1.6 1.1













Table 2: The water content of the anterior cruciate ligaments (ACLs) in the control and 
proteoglycans (PGs) reduced groups. 








Standard Deviation 4.2 3.0




























All data collected and analysed for this study are uploaded to Mendeley Data and can be accessed here:
Readioff, Rosti (2020), “The role of proteoglycans in the viscoelastic behaviour of the anterior cruciate 
ligament”, Mendeley Data, V1, doi: 10.17632/2bp2y5bk86.1














Table S1: This table shows results of a preliminary time-course study on reduction of sulphated 
glycosaminoglycans (sGAG) in anterior cruciate ligaments (ACLs). The measurements are for wet and dry 
















sGAG/mg dry weight 
(%)
Control 1 - time 0 hr 19.21 5.59 70.90 26.19 2.62
Control 2 - time 0 hr 8.93 2.69 69.88 17.30 1.73
Control 1 - time 3 hr 14.27 3.35 76.52 4.55 0.46
Control 2 - time 3 hr 10.03 2.42 75.87 33.81 3.38
Control 1 - time 6 hr 23.25 5.18 77.72 22.60 2.26
Control 2 - time 6 hr 11.62 3.16 72.81 26.15 2.62
Control 1 - time 12 hr 12.75 3.62 71.61 8.92 0.89
Control 2 - time 12 hr 28.29 6.41 77.34 9.33 0.93
Control 1 - time 24 hr 32.46 7.77 76.06 11.03 1.10
Control 2 - time 24 hr 9.61 2.24 76.69 9.16 0.92
      
1IU 1 - time 0 hr 12.23 3.84 68.60 34.30 3.43
1IU 2 - time 0 hr 15.08 4.57 69.69 31.68 3.17
1IU 1 - time 3 hr 21.57 6.33 70.65 6.37 0.64
1IU 2 - time 3 hr 9.80 2.75 71.94 1.68 0.17
1IU 1 - time 6 hr 24.69 6.57 73.39 2.15 0.21
1IU 2 - time 6 hr 15.65 3.97 74.63 11.38 1.14
1IU 1 - time 12 hr 23.95 6.48 72.94 2.70 0.27
1IU 2 - time 12 hr 21.97 5.70 74.06 3.49 0.35
1IU 1 - time 24 hr 32.32 7.27 77.51 1.62 0.16
1IU 2 - time 24 hr 24.94 6.15 75.34 2.31 0.23
      
0.5IU 1 - time 0 hr 19.10 5.67 70.31 16.45 1.64
0.5IU 2 - time 0 hr 18.53 4.43 76.09 8.15 0.82
0.5IU 1 - time 3 hr 42.42 5.30 87.51 1.30 0.13
0.5IU 2 - time 3 hr 20.15 4.34 78.46 0.75 0.08
0.5IU 1 - time 6 hr 39.54 9.57 75.80 3.26 0.33
0.5IU 2 - time 6 hr 27.18 4.52 83.37 1.75 0.17
0.5IU 1 - time 12 hr 21.10 5.27 75.02 2.63 0.26
0.5IU 2 - time 12 hr 14.74 2.40 83.72 2.11 0.21
0.5IU 1 - time 24 hr 27.74 6.02 78.30 1.45 0.14
0.5IU 2 - time 24 hr 33.52 5.38 83.95 4.37 0.44
      
0.25IU 1 - time 0 hr 14.58 4.88 66.53 17.35 1.73
0.25IU 2 - time 0 hr 23.26 6.61 71.58 21.36 2.14
0.25IU 1 - time 3 hr 17.55 4.77 76.64 3.50 0.35
0.25IU 2 - time 3 hr 15.69 3.76 74.89 3.32 0.33
0.25IU 1 - time 6 hr 20.28 4.10 76.48 1.91 0.19













0.25IU 2 - time 6 hr 14.26 3.94 73.63 2.63 0.26
0.25IU 1 - time 12 hr 18.35 3.53 80.76 1.11 0.11
0.25IU 2 - time 12 hr 15.73 3.36 78.64 0.94 0.09
0.25IU 1 - time 24 hr 30.30 4.40 85.48 0.95 0.10
0.25IU 2 - time 24 hr 20.13 4.06 79.83 0.69 0.07













Table S2: Length values of individual anterior cruciate ligaments (ACLs) at different planes. Abbreviations: 
S1-R, specimen one of the right pelvic limb and S1-L, specimen one of the left pelvic limb.
Control
Anterior (mm) Posterior (mm) Medial (mm) Lateral (mm) Mean (mm) SD (mm) CV (%)
S1-R 23.86 9.07 17.63 17.74 17.08 6.08 36
S2-R 20.51 11.31 13.6 15.61 15.26 3.92 26
S3-R 20.04 10.92 18.72 13.66 15.84 4.28 27
S4-R 23.96 13.19 19.29 20.57 19.25 4.50 23
S5-R 20.71 11.27 11.88 14.47 14.58 4.31 30
S6-R 19.49 10.9 14.76 19.16 16.08 4.07 25
PG reduced
Anterior (mm) Posterior (mm) Medial (mm) Lateral (mm) Mean (mm) SD (mm) CV (%)
S1-L 21.97 10.8 18.54 16.08 16.85 4.70 28
S2-L 21.88 13.76 16.85 18.18 17.67 3.36 19
S3-L 19.76 11.3 15.44 16.83 15.83 3.52 22
S4-L 21.92 14.38 15.61 16.29 17.05 3.34 20
S5-L 22.45 11.52 15.52 18.04 16.88 4.58 27
S6-L 19.95 11.51 14.03 13.22 14.68 3.67 25













Table S3: Cross-sectional areas (CSA) of individual anterior cruciate ligaments (ACLs). Abbreviations: S1-
R, specimen one of the right pelvic limb; S1-L, specimen one of the left pelvic limb.
Control PG reduced
CSA (mm2) CSA (mm2)
S1-R 20.14 S1-L 29.21
S2-R 25.80 S2-L 31.57
S3-R 24.05 S3-L 20.81
S4-R 20.43 S4-L 28.92
S5-R 17.98 S5-L 16.07
S6-R 29.29 S7-L 21.24












































Figure S1: This figure is based on the data presented in Supplementary Materials (Table S3). The figure 
shows a decrease in sulphated glycosaminoglycan (sGAG) content (%) in the anterior cruciate ligaments 
(ACLs) with increasing incubation time for four chondroitinase ABC (ChABC) concentration levels. Results 
indicate that after three hours incubation in 0.25IU/ml ChABC, approximately 82.3% of sGAG is depleted.














































Figure S2: Stress-strain behaviour of the anterior cruciate ligaments (ACLs) during load (solid lines) and 
unload (dashed lines) tensile tests in the control (red shaded line) and proteoglycans reduced (black shaded 
line) groups at 0.1, 1 and 10 %/min strain-rates. 

































Figure S3: Creep behaviour of the anterior cruciate ligaments (ACLs) in the control and proteoglycans 
reduced groups when a constant load of 4.9 N and 9.9 N were applied for 15 minutes each. 













Specimen 1 Specimen 2
Specimen 3 Specimen 4
Specimen 5 Specimen 6
Figure S4: Stress-relaxation behaviour of the anterior cruciate ligaments (ACLs) in the control and 
proteoglycans reduced groups when deformation, caused by a load of 9.9 N, was held for 15 minutes. 
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